Qingdao Haier Biomedical Hits Day Low at CNY 29.82 Amid Price Pressure

Qingdao Haier Biomedical Co., Ltd. experienced a significant decline today, with the stock dropping by 5.52% on March 23, 2026. The stock reached an intraday low of CNY 29.82, reflecting ongoing challenges faced by the company. Over the past week, the stock has seen a decrease of 8.65%, and its performance over the last month stands at a decline of 7.75%. In the context of the broader market, the China Shanghai Composite index fell by 3.63% today, indicating that Qingdao Haier Biomedical's performance is notably weaker than the market average. The company has struggled with consistent underperformance, with a staggering 55.95% drop over the past three years and a 63.69% decline over the last five years. Financial metrics reveal a concerning trend, with net profit for the half-year at CNY 86.33 million, down 49.8%. The return on equity is at a modest 5.92%, and the company has reported negative results for eight consecutive quarters. As a mid-cap player in the industrial manufacturing sector, Qingdao Haier Biomedical continues to face significant hurdles in its financial performance.